TrialCell reports. Medicine2025

Epigenetic profiling identifies markers of endocrine resistance and therapeutic options for metastatic castration-resistant prostate cancer.

Tesa M Severson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.